Xi Yao | Cancer Cell Biology | Best Researcher Award

Dr. Xi Yao | Cancer Cell Biology | Best Researcher Award

Dr. Xi Yao , Yunnan University , China

Xi Yao is a prominent researcher in the field of vertebrate evolutionary biology, specializing in dinosaur studies. Currently based at Yunnan University, Kunming, China, he is affiliated with the Center for Vertebrate Evolutionary Biology. With a background in Geology (Bachelor’s from Northwest University, China), Yao further honed his expertise in Vertebrate Paleontology through his Master’s and Ph.D. from the Institute of Vertebrate Paleontology and Paleoanthropology, Chinese Academy of Sciences. He has actively participated in several fossil excavation projects across China, particularly in Xinjiang, Neimongol, and Yunnan, focusing on Jurassic and Cretaceous dinosaur species. His research contributions have garnered recognition in the scientific community with numerous publications in prestigious journals and an active collaboration with international experts.

Publication Profile:

Orcid

Strengths for the Award:

Xi Yao is a highly accomplished paleontologist with a strong background in dinosaur research, specifically focusing on vertebrate evolution and systematics. His educational journey, from a Geology degree to a Master’s and Ph.D. in Vertebrate Paleontology, reflects his deep-rooted expertise in the field. His active role at Yunnan University has allowed him to contribute significantly to understanding the evolution of dinosaur species, particularly in the Jurassic and Cretaceous periods. Notably, his groundbreaking studies on early Jurassic ornithischian dinosaurs and tyrannosauroid locomotion, coupled with his extensive fieldwork across China, position him as a leading expert in dinosaur paleontology. His collaborations with international researchers, such as Prof. John Hutchinson from the Royal Veterinary College and Prof. Corwin Sullivan from the University of Alberta, strengthen his global presence in the scientific community. His publications in well-regarded journals like iScience, Cretaceous Research, and Elife highlight his impactful contributions.

Areas for Improvement:

While Xi Yao has made substantial contributions to dinosaur paleontology, an area for improvement would be expanding his outreach and professional memberships. Engaging more actively with larger paleontological communities and taking editorial roles in academic journals could further boost his visibility and influence. In addition, he has not published books or patents, which are often essential for showcasing a comprehensive body of work in paleontology.

Education:

Xi Yao completed his Bachelor’s degree in Geology from Northwest University, China, laying a foundation in earth sciences. He furthered his academic career at the Institute of Vertebrate Paleontology and Paleoanthropology (IVPP) of the Chinese Academy of Sciences in Beijing, earning both his Master’s and Ph.D. in Vertebrate Paleontology. During his graduate studies, Yao focused on dinosaur evolution and systematics, particularly the study of fossil evidence and ancient ecosystems. His educational journey reflects a blend of geological and paleontological expertise, which supports his comprehensive research on prehistoric life, including the evolutionary trends in dinosaur species. His work at Yunnan University allows him to continue applying his interdisciplinary knowledge to the study of dinosaur fossils, emphasizing both anatomical and ecological perspectives. His academic achievements also include collaborating with other renowned researchers globally, broadening his scientific impact.

Experience:

Xi Yao has accumulated extensive experience in the field of paleontology through both research and fieldwork. After completing his higher education, he became an integral member of the research community at Yunnan University, where he specializes in vertebrate evolutionary biology, particularly dinosaurs. His fieldwork has taken him to several notable excavation sites across China, including Xinjiang, Neimongol, and Yunnan Province, where he has contributed significantly to discovering and analyzing dinosaur fossils. His ongoing research on tyrannosauroid locomotion and dinosaur evolution is supported by grants from prestigious agencies such as the National Natural Science Foundation of China. He has also forged collaborations with leading paleontologists, such as Prof. John Hutchinson from the Royal Veterinary College in the UK, and Prof. Corwin Sullivan from the University of Alberta, Canada. Xi Yao’s extensive hands-on experience in excavations, along with his academic contributions, make him a valuable figure in his field.

Research Focus:

Xi Yao’s primary research interest lies in dinosaur evolution, with a focus on both Jurassic and Cretaceous species. His work has contributed to the understanding of dinosaur phylogeny, anatomy, and locomotion, particularly through his studies on theropods and ornithischians. One of his significant projects involves studying the locomotion of tyrannosauroids through digital modeling, which explores how these iconic predators moved and interacted with their environment. Additionally, he has reported groundbreaking findings on rare early Jurassic ornithischians in Southern China, making important contributions to the understanding of dinosaur diversity during this period. His studies also extend to the description of new dinosaur species, including oviraptorosaurians, therizinosaurians, and ornithomimosaurians, primarily in the Cretaceous of northern China. This focus on dinosaur systematics not only enriches the scientific community’s understanding of dinosaur lineage but also sheds light on broader evolutionary patterns of life on Earth.

Publications Top Notes:

  • “New evidence for the earliest ornithischian dinosaurs from Asia” 📜 (iScience, 2024)
  • “A new ankylosaurid dinosaur from the Upper Cretaceous of Jiangxi Province, southern China” 🦕 (Historical Biology, 2024)
  • “New ornithomimosaurian pelvis from the Upper Cretaceous Erlian Formation of Nei Mongol, North China” 🦖 (Cretaceous Research, 2022)
  • “A new early branching armored dinosaur from the Lower Jurassic of southwestern China” 🛡️ (Elife, 2022)
  • “A new transitional therizinosaurian theropod from the Early Cretaceous Jehol Biota of China” 🦖 (Scientific Reports, 2019)
  • “Caenagnathasia sp. from the Iren Dabasu Formation of Erenhot, Nei Mongol, China” 🦕 (Vertebrata PalAsiatica, 2015)

Conclusion:

Xi Yao is an exceptional candidate for the Best Researcher Award due to his outstanding contributions to the field of dinosaur evolution and systematics. His research has not only expanded our understanding of dinosaur diversity but has also provided new insights into locomotion and dinosaur phylogeny. His dedication to fieldwork and collaboration with international researchers adds value to his research endeavors. Despite some areas for improvement, such as increased professional memberships and diversification of publications, his overall achievements place him among the top researchers in the field. Therefore, Xi Yao deserves strong consideration for this prestigious award.

 

 

 

Yingrong Du | Liver diseases | Best Researcher Award

Prof. Yingrong Du | Liver diseases | Best Researcher Award

Prof. Yingrong Du , The Third People’s Hospital of Kunming , China

Dr. Du Yingrong is a Chief Physician at Dali University’s Sixth Affiliated Hospital (Kunming Third People’s Hospital), specializing in cardiovascular medicine. With over three decades of experience, Dr. Du has made significant contributions to clinical medicine and healthcare management. He is dedicated to advancing patient care, particularly in cardiovascular health, and is actively involved in several research projects, particularly in the areas of atherosclerosis and chronic non-communicable diseases. Dr. Du has also focused on improving healthcare systems in rural China and addressing public health challenges such as COVID-19. His expertise extends to both clinical work and hospital management

Publication Profile:

Scopus

Strengths for the Award:

Dr. Du Yingrong demonstrates exceptional expertise in both clinical medicine and research, making significant contributions in cardiovascular health, atherosclerosis, and public health. He has a strong academic background with advanced education in Hospital Management and Clinical Medicine. As the Chief Physician at Dali University’s Sixth Affiliated Hospital, he has exhibited leadership in managing cardiovascular care, implementing innovative emergency treatment systems, and addressing healthcare disparities in rural China. Dr. Du has led and participated in several research projects funded by the National Natural Science Foundation of China and local government bodies, showcasing his commitment to scientific advancement and public health improvements.

Areas for Improvement:

While Dr. Du has made remarkable strides in research, further enhancing the interdisciplinary collaboration across different health sectors could strengthen his future projects. Expanding his research into broader, international contexts, and diversifying his focus to include emerging areas in global healthcare trends could also provide additional opportunities for groundbreaking research.

Education:

Dr. Du completed his Master’s Degree in Hospital Management from Flinders University and Nankai University (2012-2014). Prior to this, he earned his Bachelor’s Degree in Clinical Medicine from Kunming Medical University (1988-1992). His strong educational foundation has supported his distinguished career in both medical practice and healthcare administration, particularly in managing complex clinical departments and participating in innovative research efforts in cardiovascular health.

Experience:

Dr. Du has extensive experience at Dali University’s Sixth Affiliated Hospital (Kunming Third People’s Hospital), where he has worked since 1992. Starting as a physician in the Cardiovascular Department, he advanced through roles such as Attending Physician, Deputy Chief Physician, and ultimately Chief Physician. His leadership and expertise have significantly contributed to the hospital’s growth, particularly in the cardiovascular field. Dr. Du has been instrumental in several key research projects, such as optimizing emergency treatment systems for COVID-19 and exploring health disparities in minority populations in Yunnan province.

Research Focus:

Dr. Du’s research focus spans cardiovascular diseases, atherosclerosis, public health, and minority health disparities. He has been involved in multiple National Natural Science Foundation and local government-funded projects. His key research interests include studying the effects of triterpenoid compounds on atherosclerosis and exploring clinical treatment methods for chronic diseases in underserved populations. His work aims to improve healthcare delivery, treatment efficacy, and the cultural competence of medical professionals, especially in minority areas of China.

Publications Top Notes:

  1. Ethnic disparities in the prevalence of chronic non-communicable diseases and its multimorbidity among older adults in rural southwest China 📚🌍
  2. Inflammation markers and the risk of hypertension in people living with HIV 🩺🔥
  3. New cycloartane triterpenes from the roots of Cimicifuga foetida 🌿💡
  4. Omega-6 fatty acids down-regulate matrix metalloproteinase expression in a coronary heart disease-induced rat model 🐀💪

Conclusion:

Dr. Du Yingrong is a highly qualified and dedicated researcher who has made significant contributions to clinical medicine and healthcare research. His leadership in addressing cardiovascular health, minority health disparities, and the COVID-19 pandemic exemplifies his ability to combine clinical expertise with impactful research. He is undoubtedly a strong candidate for the “Best Researcher Award,” with his ongoing contributions to healthcare and public health paving the way for significant improvements in both clinical practice and health system management.

 

 

 

Mai Kadry | Molecular chemistry | Best Researcher Award

Assist. Prof. Dr. Mai Kadry | Molecular chemistry | Best Researcher Award

Assist. Prof. Dr. Mai Kadry , National Research Center , Egypt

Mai Osman Mohamed Kadry is a dedicated biochemist, currently working as a researcher in the Therapeutic Chemistry Department at the National Research Centre, Cairo, Egypt. She holds a Doctorate in Biochemistry from Cairo University (2016) and an MSc in Pharmaceutical Sciences from Helwan University (2008). Her primary expertise lies in the field of therapeutic chemistry, with a focus on the biochemical effects of various treatments and their therapeutic potential. In addition to her research, Kadry has academic experience, having taught pharmacognosy at 6 October University. Her work often involves exploring the effects of nanotechnology, antioxidants, and herbal medicines on oxidative stress, toxicity, and cancer treatment. Kadry has contributed significantly to several projects and has published numerous research papers in high-impact journals. She is a well-rounded professional with strong training in various biochemical techniques and computational tools.

Publication Profile:

Scopus

Strengths for the Award:

  1. Academic and Professional Background:
    • Mai Kadry holds a Doctoral degree in Biochemistry, showcasing a high level of academic commitment and specialization. Her focus on cutting-edge research topics such as the amelioration of titanium dioxide-induced oxidative injury, as well as her studies on pharmaceutical and biochemical sciences, highlights her expertise.
    • She has a significant teaching background in the academic field, particularly in the area of pharmacognosy, demonstrating her ability to contribute to the development of future researchers in the field.
  2. Research Output and Publications:
    • Kadry has made substantial contributions to scientific literature, particularly in toxicology and therapeutic chemistry, with numerous research articles published in reputable journals. This includes studies on nano-formulations, the effects of titanium dioxide, and the therapeutic potential of resveratrol.
    • Her involvement in various high-impact research papers underlines her dedication to advancing her field. Additionally, the growing citation of her work further demonstrates the relevance and influence of her research.
  3. Collaboration and Research Initiatives:
    • Kadry has actively participated in multiple innovative research projects at the National Research Centre, focusing on important areas such as nanobiotechnology, hepatocellular carcinoma, and diabetes treatment.
    • Her interdisciplinary approach, involving metabolomics, nanotechnology, and toxicity assessments, shows a broad and comprehensive research capacity, critical for addressing complex health challenges.
  4. Training and Expertise:
    • Kadry has participated in numerous training courses, covering vital techniques like PCR, ELISA, HPLC, and bioinformatics, further strengthening her methodological skills.
    • Her expertise extends to a range of laboratory techniques that are essential for high-quality research in biochemistry and therapeutic chemistry, ensuring the reliability and depth of her scientific investigations.

Areas for Improvement:

  1. Broader Recognition and Networking:
    • While Kadry has published extensively, there could be more emphasis on expanding her research network internationally. Increased participation in global conferences and collaborative research could further elevate her reputation.
  2. Public Outreach and Communication:
    • Enhancing public awareness of her research, possibly through outreach programs or public lectures, could help bridge the gap between scientific research and society. This would make her research more accessible and valuable for a wider audience.
  3. Interdisciplinary Application:
    • While Kadry has shown proficiency in fundamental biochemical research, exploring interdisciplinary applications of her work could bring new insights. For example, connecting her findings to practical medical treatments or developing clinical applications could offer significant real-world value.

Education:

Mai Osman Mohamed Kadry earned her Doctoral degree in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a dissertation titled “Amelioration Of Nano-sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She holds a Master of Science in Pharmaceutical Sciences from Helwan University (2008), where her research focused on “The Possible Synergistic Role of Phytic and Catechin in Ameliorating the Deteriorative Biochemical Effects Induced By Carbon Tetrachloride in Rats.” Kadry completed her B.Sc. in Pharmaceutical Sciences at Ain Shams University in 2003, graduating with honors and a cumulative grade of Very Good. In addition to her academic qualifications, she has participated in various training courses, including bioinformatics, biosstatistics, scientific typewriting, and protein electrophoresis at the National Research Centre. Her education has provided a robust foundation in pharmaceutical science and biochemistry.

Experience:

Mai Osman Mohamed Kadry has over a decade of academic and research experience in biochemistry and pharmaceutical sciences. She worked as a researcher in the Therapeutic Chemistry Department at the National Research Centre, Cairo, Egypt, where she contributed to multiple research projects related to nanobiotechnology, metabolomics, and the therapeutic efficacy of herbal and chemical entities in treating cancer and diabetes. In her academic career, she taught pharmacognosy at 6 October University (2003-2004) and participated in academic development and quality assurance according to National Commission for Academic Accreditation standards. Kadry’s extensive research experience includes involvement in projects investigating the effects of nanoparticles, herbal medications, and novel chemical compounds on oxidative stress, liver injury, and cancer. She is proficient in a variety of biochemical laboratory techniques, including PCR, ELISA, and HPLC, which have been essential for her research efforts.

Research Focus:

Mai Osman Mohamed Kadry’s research focuses on the biochemical effects of various therapeutic agents, particularly in the areas of nanotechnology, antioxidants, and their role in combating oxidative stress, toxicity, and cancer. Her research aims to explore the potential of nanoparticles, such as titanium dioxide, in ameliorating damage caused by oxidative stress in mice models. She is deeply involved in projects related to the therapeutic properties of herbal medications and chemical entities in treating diseases like liver cancer and diabetes. Kadry is also interested in examining the synergistic effects of natural compounds, such as catechin and phytic acid, in mitigating biochemical damage induced by toxic substances like carbon tetrachloride. Her work further extends to studying autophagy and cell death pathways in response to chemotherapy and other therapeutic agents. Through her research, Kadry seeks to identify novel treatments and biomarkers that can improve the safety and efficacy of therapies for various diseases.

Publications Top Notes:

  1. Titanium nanostructure mitigating doxorubicin–induced testicular toxicity in rats via regulating major autophagy signaling pathways 🧬💉
  2. Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine 🧠🩺
  3. Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding their prognostic and diagnostic potential 🩸🔬
  4. Resveratrol-based nano-formulations as an emerging therapeutic strategy for ovarian carcinoma: autophagy stimulation and SIRT-1/Beclin/MMP-9/P53/AKT signaling 💊🌿
  5. miR-122-IGF-1R signaling allied through the dysregulated lncRNA MALAT-1 expression in gastric carcinoma 🍽️🧬
  6. Reciprocal crosslink among MeCP2/BDNF /CREB signaling pinpointed in autism spectrum disorder 🤯🔗
  7. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds 🧬💉
  8. Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study 🧬🩺
  9. Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling 💉🧬
  10. Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk 💪💊

Conclusion:

Mai Osman Mohamed Kadry demonstrates remarkable potential and has made valuable contributions to the fields of biochemistry and therapeutic chemistry. Her academic background, research output, and active involvement in high-impact projects make her a strong contender for the “Best Researcher Award.” While there is room for growth in terms of global outreach and practical applications, her work undoubtedly plays a crucial role in advancing scientific knowledge, particularly in toxicology and the therapeutic use of nanomaterials. Therefore, she is highly deserving of consideration for this prestigious award.